A snow-balling momentum in establishing new facilities both in bulk drugs and formulations for the regulated markets, securing approvals from international regulatory authorities and generating intellectual property has resulted in a strategic transformation in Orchid's business profile. Orchid has also commissioned a pre-clinical toxicology and pharmacology centre, located in the R&D campus to aid pre-clinical trials.

Orchid is one of the few pharmaceutical companies of its size and scale to have received the ISO 9001:2000, ISO 14001 and OHSAS 18001 certifications for its world-class quality, environmental management systems and Operational Health & Safety systems respectively.